Determine atrial fibrillation burden with a photoplethysmographic mobile sensor: the atrial fibrillation burden trial: detection and quantification of episodes of atrial fibrillation using a cloud analytics service connected to a wearable with photoplethysmographic sensor

Recent studies suggest that atrial fibrillation (AF) burden (time AF is present) is an independent risk factor for stroke. The aim of this trial was to study the feasibility and accuracy to identify AF episodes and quantify AF burden in patients with a known history of paroxysmal AF with a photoplethysmography (PPG)-based CardioWatch 287.

European Heart Journal - Digital Health, ztad039, https://doi.org/10.1093/ehjdh/ztad039

Pamela Reissenberger 1, Peter Serfözö 1, Diana Piper 2, Norman Juchler 3, Sara Glanzmann 1, Jasmin Gram 1, Karina Hensler 1, Hannah Tonidandel 1, Elena Börlin 4, Marcus D’Souza 4,5, Patrick Badertscher 6, and Jens Eckstein 1,4

  1. Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
  2. Preventicus, Ernst-Abbe-Str. 15, 07743 Jena, Germany
  3. Institute of Computational Life Sciences, Zurich University of Applied Sciences, Schloss 1, 8820 Wädenswil, Switzerland
  4. Department Digitalization & ICT, University Hospital Basel, Spitalstrasse 26, 4031 Basel, Switzerland
  5. Department of Neurology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
  6. Department of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland